Biotechnology

Techseriesinsight > Blog > News > Biotechnology

February 16, 2026
Business Wire
Biotechnology, News

SC Infliximab Retreatment Shows Sustained Efficacy After Drug Holiday

SC infliximab retreatment has demonstrated the ability to restore and maintain disease control in patients with inflammatory bowel disease after a treatment interruption. New findings from Celltrion, Inc. show...

February 13, 2026
PRNewswire
Biotechnology, News

HanchorBio FDA Orphan Drug Designation Boosts HCB101 for Gastric Cancer

HanchorBio has achieved a major regulatory milestone with the HanchorBio FDA orphan drug designation for HCB101. The designation supports the development of the company’s next-generation immunotherapy for gastric cancer,...

February 12, 2026
Business Wire
Biotechnology, News

EKTERLY Data: KalVista to Showcase Sebetralstat Research at AAAAI 2026

KalVista Pharmaceuticals announced it will present new EKTERLY data at the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. The event will take place in Philadelphia...

February 12, 2026
Business Wire
Biotechnology, News

Zeon Invests in Chemify to Advance Digital Chemistry Innovation

Zeon Chemify investment marks a strategic move to accelerate digital chemistry and automated molecular design. Zeon Corporation, through Zeon Ventures, has partnered with UK-based Chemify to speed up the...

February 12, 2026
PRNewswire
Biotechnology, News

Berlin Heals Raises $10M to Advance Less Invasive Heart Failure Therapy

Berlin Heals funding has surpassed $10 million following a newly completed financing round aimed at expanding access to its less invasive heart failure treatment. The MedTech company secured investments...

February 11, 2026
Business Wire
Biotechnology, News

Sandy Voss Appointment: Joins Life Science Connect as SVP

Sandy Voss Appointment: Life Science Connect Names New SVP of Live Events The Sandy Voss appointment as Senior Vice President of Live Events marks a major step for Life...

February 11, 2026
PRNewswire
Biotechnology, News

Akeso’s Bispecific Antibody AK139 Approved for Seven Phase II Trials in China

Akeso Advances AK139 Bispecific Antibody into Phase II Trials Akeso, Inc. (9926.HK) has received approval from China’s National Medical Products Administration (NMPA) to begin Phase II clinical trials for...

February 11, 2026
Business Wire
Biotechnology, News

Dxcover Launches Blood Test for Early Brain Cancer Detection in the UK

Dxcover Launches Brain Cancer Blood Test to Support Earlier Diagnosis Dxcover, a global leader in AI-enabled diagnostics, has launched a brain cancer blood test in the UK following UKCA...

February 11, 2026
PRNewswire
Biotechnology, News

Arctic Therapeutics Enrolls First Patients in Phase IIa Trial of AT-004 for Acne Vulgaris

Arctic Therapeutics (ATx) has enrolled the first patients in its Phase IIa randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of topical AT-004 for treating acne...

February 10, 2026
PRNewswire
Biotechnology, News

ArrayPatch Announces First Close of €3M Seed Round to Advance ITZ-DerMap™ for Treatment of Nail Fungus

ArrayPatch Ltd, a biotech company developing innovative microneedle-based therapeutics, today announced the first close of its €3 million seed funding round, to advance its lead program ITZ-DerMap™, a novel...